Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.76B 700M 615M 566M 527M 995M 66.58B 1.01B 6.81B 2.64B 32.68B 2.63B 2.57B 114B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.59B 675M 593M 546M 509M 959M 64.22B 979M 6.57B 2.54B 31.52B 2.54B 2.48B 110B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day+7.43%
1 week-0.12%
Current month+7.43%
1 month-0.72%
3 months-21.22%
6 months+3.78%
Current year+3.78%
1 week 7.08
Extreme 7.08
8.28
1 month 7.08
Extreme 7.08
8.43
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
15.85
Manager TitleAgeSince
Chief Executive Officer 42 11/12/2017
Director of Finance/CFO 34 01/08/2019
Chief Operating Officer 45 25/08/2022
Director TitleAgeSince
Chairman 42 01/08/2019
Chairman 48 21/03/2019
Director/Board Member 46 21/03/2019
Date Insider Type Main position Quantity % Market Cap.
14/09/21Sell

Executive/Senior Manager

10,000 0.0025%
10/09/21Sell

Executive/Senior Manager

77,000 0.0189%
09/06/21Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
+7.43%-0.12%-16.85%+24.10% 705M
+0.04%+6.67%+53.59%+154.11% 1,063B
+0.61%+5.39%+62.89%+53.44% 611B
+0.21%+6.88%+32.14%+86.34% 444B
+2.55%-0.96%+26.12%+20.22% 324B
+2.51%+0.57%+36.11%+36.32% 285B
+1.04%+0.21%+28.27%+42.60% 283B
+1.09%+2.98%-26.38%-39.95% 219B
+0.69%+2.82%+24.37%+62.75% 195B
+0.60%+0.65%+12.75%+63.45% 156B
Average +1.72%+3.18%+23.30%+50.34% 358.14B
Weighted average by Cap. +0.86%+4.16%+38.37%+77.39%

Financials

2024 2025
Net sales 984M 145M 127M 117M 109M 206M 13.76B 210M 1.41B 545M 6.76B 544M 532M 23.51B 1.21B 177M 156M 143M 134M 252M 16.87B 257M 1.72B 668M 8.28B 666M 652M 28.81B
Net income 13.65M 2.01M 1.76M 1.62M 1.51M 2.85M 191M 2.91M 19.53M 7.57M 93.77M 7.54M 7.38M 326M 92.73M 13.65M 11.98M 11.03M 10.28M 19.38M 1.3B 19.78M 133M 51.4M 637M 51.25M 50.14M 2.22B
Net Debt 189M 27.83M 24.43M 22.49M 20.96M 39.53M 2.65B 40.33M 271M 105M 1.3B 104M 102M 4.52B -169M -24.85M -21.81M -20.08M -18.71M -35.29M -2.36B -36M -242M -93.57M -1.16B -93.29M -91.27M -4.04B
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
01/07/26 CN¥8.240 +7.43% 38,713,870
30/06/26 CN¥7.670 -2.29% 23,485,763
29/06/26 CN¥7.850 +8.58% 31,887,683
26/06/26 CN¥7.230 -6.71% 22,752,583
25/06/26 CN¥7.750 -6.06% 32,299,297

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock